Eptifibatide
NDC 70436-027, eptifibatide, injection, from Slate Run Pharmaceuticals, LLC.
- Product NDC
- 70436-027
- Status
- Listed
- Labeler
- Slate Run Pharmaceuticals, LLC
- Dosage form
- INJECTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA209864
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/70436-027 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- EPTIFIBATIDE.75 mg/mL
Pharmacologic classes
Decreased Platelet Aggregation [PE]; Platelet Aggregation Inhibitor [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 70436-027-80 | 70436002780 | 100 mL in 1 VIAL (70436-027-80) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/da421d88-6c00-428a-82a6-b3b4f7a68b85
Use it
Look up 70436-027 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/70436-027 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 70436-027. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.